Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults. 2013

Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
Department of Experimental Immunology, Academic Medical Centre, Amsterdam, The Netherlands. m.c.vanaalderen@amc.uva.nl

The human polyomavirus BK virus (BKV) establishes a latent and asymptomatic infection in the majority of the population. In immunocompromised individuals, the virus frequently (re)activates and may cause severe disease such as interstitial nephritis and hemorrhagic cystitis. Currently, the therapeutic options are limited to reconstitution of the antiviral immune response. T cells are particularly important for controlling this virus, and T cell therapies may provide a highly specific and effective mode of treatment. However, little is known about the phenotype and function of BKV-specific T cells in healthy individuals. Using tetrameric BKV peptide-HLA-A02 complexes, we determined the presence, phenotype, and functional characteristics of circulating BKV VP1-specific CD8(+) T cells in 5 healthy individuals. We show that these cells are present in low frequencies in the circulation and that they have a resting CD45RA(-) CD27(+) memory and predominantly CCR7(-) CD127(+) KLRG1(+) CD49d(hi) CXCR3(hi) T-bet(int) Eomesodermin(lo) phenotype. Furthermore, their direct cytotoxic capacity seems to be limited, since they do not readily express granzyme B and express only little granzyme K. We compared these cells to circulating CD8(+) T cells specific for cytomegalovirus (CMV), Epstein-Barr virus (EBV), and influenza virus (Flu) in the same donors and show that BKV-specific T cells have a phenotype that is distinct from that of CMV- and EBV-specific T cells. Lastly, we show that BKV-specific T cells are polyfunctional since they are able to rapidly express interleukin-2 (IL-2), gamma interferon (IFN-γ), tumor necrosis factor α, and also, to a much lower extent, MIP-1β and CD107a.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001739 BK Virus A species of POLYOMAVIRUS apparently infecting over 90% of children but not clearly associated with any clinical illness in childhood. The virus remains latent in the body throughout life and can be reactivated under certain circumstances. BK polyomavirus,Human Polyomavirus BK,Polyomavirus, BK,Polyomavirus hominis 1,Polyomavirus BK, Human
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D016176 T-Lymphocyte Subsets A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells. T-Cell Subset,T-Cell Subsets,T-Lymphocyte Subset,Subset, T-Cell,Subset, T-Lymphocyte,Subsets, T-Cell,Subsets, T-Lymphocyte,T Cell Subset,T Cell Subsets,T Lymphocyte Subset,T Lymphocyte Subsets
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
April 2020, Pediatric nephrology (Berlin, Germany),
Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
January 2011, Methods in molecular biology (Clifton, N.J.),
Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
August 2018, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation,
Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
May 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
November 2008, Human immunology,
Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
September 2007, Vaccine,
Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
April 2002, Journal of immunology (Baltimore, Md. : 1950),
Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
September 2007, Viral immunology,
Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
June 2010, Leukemia & lymphoma,
Michiel C van Aalderen, and Ester B M Remmerswaal, and Kirstin M Heutinck, and Anja ten Brinke, and Hanspeter Pircher, and René A W van Lier, and Ineke J M ten Berge
October 2014, Transplant infectious disease : an official journal of the Transplantation Society,
Copied contents to your clipboard!